Safety and Efficacy of Lucitanib Plus Toripalimab in Advanced Solid Tumors Refractory to Standard Therapies: An Open-Label, Multicenter, Phase II Study
Lucitanib联合Toripalimab治疗对标准疗法耐药的晚期实体瘤的安全性和有效性:一项开放标签、多中心、II期研究
期刊:MedComm
影响因子:10.7
doi:10.1002/mco2.70672
Zhou, Ting; Sun, Haishuang; Chen, Gang; Zhang, Guoping; Wu, Jinsheng; Qu, Shenhong; Han, Yaqian; Hu, Desheng; Ling, Yang; Zheng, Yulong; Liu, Jian; Lin, Lizhu; Li, Yongsheng; Pan, Jianji; Liu, Yanyan; Wang, Cuiying; Fu, Guohong; Feng, Jian; Shi, Jianhua; Cai, Huiming; Li, Meng; Li, Fugen; Wang, Yinbin; Zhang, Li; Yang, Yunpeng